SCHEMBL4617440

SCHEMBL4617440

COc1ccc(CNS(=O)(=O)c2cc(S(=O)(=O)c3ccc(F)cc3)ccc2C)cc1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
CYP19A1 P11511 1/20 0.52
CNR2 P34972 1/20 0.52
LMNA P02545 3/20 0.51
TSHR P16473 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HTT P42858 1/20 0.51
TP53 P04637 2/20 0.51
THRB P10828 3/20 0.50
USP2 O75604 1/20 0.50
KDM4E B2RXH2 1/20 0.50
MAPK1 P28482 1/20 0.50
BAZ2B Q9UIF8 1/20 0.50
SFRP1 Q8N474 1/20 0.49
MAPT P10636 2/20 0.48
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4619139 0.90 ALDH1A1 (0.64) ALDH1A1CYP19A1CNR2LMNATSHR
SCHEMBL4617591 0.89 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2TP53SFRP1MAPT
SCHEMBL6102121 0.89 ALDH1A1 (0.58) ALDH1A1CYP19A1CNR2LMNATSHR
SCHEMBL1893565 0.84 ALDH1A1 (0.76) ALDH1A1CYP19A1LMNATSHRSMN1; SMN2
SCHEMBL4616336 0.82 SFRP1 (0.61) ALDH1A1LMNASMN1; SMN2HTTKDM4E
SCHEMBL6100257 0.80 SFRP1 (0.64) ALDH1A1SMN1; SMN2SFRP1MAPT
SCHEMBL4618887 0.80 SFRP1 (0.75) ALDH1A1SMN1; SMN2HTTTP53THRB
SCHEMBL4617536 0.80 SFRP1 (0.67) ALDH1A1SMN1; SMN2SFRP1
SCHEMBL6103669 0.79 MAPT (0.52) ALDH1A1LMNASMN1; SMN2TP53USP2
SCHEMBL4617259 0.79 SMN1; SMN2 (0.56) ALDH1A1LMNATSHRSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 ALDH1A1 1865/4885CYP19A1 1047/4885CNR2 3896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.